These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15045816)

  • 21. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.
    Tung CH; Lai NS; Li CY; Tsai SJ; Chen YC; Chen YC
    BMJ Open; 2018 Jul; 8(7):e021747. PubMed ID: 30037875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.
    Marcellin P; Descamps V; Martinot-Peignoux M; Larzul D; Xu L; Boyer N; Pham BN; Crickx B; Guillevin L; Belaich S
    Gastroenterology; 1993 Jan; 104(1):272-7. PubMed ID: 8380394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arthritis in patients with chronic hepatitis C virus infection.
    Rivera J; García-Monforte A; Pineda A; Millán Núñez-Cortés J
    J Rheumatol; 1999 Feb; 26(2):420-4. PubMed ID: 9972979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
    Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A
    Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed cryoglobulinemia and hepatitis C virus.
    Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
    Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
    Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryoglobulinemia vasculitis: how to handle.
    Desbois AC; Comarmond C; Saadoun D; Cacoub P
    Curr Opin Rheumatol; 2017 Jul; 29(4):343-347. PubMed ID: 28368978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    Acta Gastroenterol Belg; 2013 Dec; 76(4):363-71. PubMed ID: 24592538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
    Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
    Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of MPO-ANCA-related microscopic polyangiitis with mixed cryoglobulinemia].
    Asai O; Nakatani K; Yoshimoto S; Akai Y; Nishino T; Iwano M; Shiiki H; Saito Y
    Nihon Jinzo Gakkai Shi; 2006; 48(4):377-84. PubMed ID: 16780108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia.
    Liu FC; Chao YC; Hou TY; Chen HC; Shyu RY; Hsieh TY; Chen CH; Chang DM; Lai JH
    Clin Rheumatol; 2008 Apr; 27(4):463-7. PubMed ID: 17876647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
    Staak JO; Glossmann JP; Diehl V; Josting A
    Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study.
    Mazzaro C; Monti G; Saccardo F; Zignego AL; Ferri C; De Vita S; Gabrielli A; Lenzi M; Donada C; Galli M; Pietrogrande M; Pozzato G
    Clin Exp Rheumatol; 2011; 29(6):933-41. PubMed ID: 22153224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribavirin in hepatitis C related cryoglobulinemia.
    Durand JM; Cacoub P; Lunel-Fabiani F; Cosserat J; Cretel E; Kaplanski G; Frances C; Bletry O; Soubeyrand J; Godeau P
    J Rheumatol; 1998 Jun; 25(6):1115-7. PubMed ID: 9632073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal change disease in a patient receiving IFN-alpha therapy for chronic hepatitis C virus infection.
    Dizer U; Beker CM; Yavuz I; Ortatatli M; Ozguven V; Pahsa A
    J Interferon Cytokine Res; 2003 Jan; 23(1):51-4. PubMed ID: 12639299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.